Chronic management care company Vivante Health has raised USD 31 million in a Series B funding round led by Mercato Partners with participation from investors such as Health Catalyst Capital, 7wireVentures, and Intermountain Ventures. This brings the total funds raised by the company to USD 47 million.
The funds will support Vivante’s technology upgrades to predict and manage gastrointestinal (GI) conditions as well as the expansion of commercial and client support teams.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.